virus-specific T cells

Cell therapyexperimental

Clinical trial activity

8 trials · 10 clinical orgs · 0 marketing orgs

Phase 1
6
Phase 2
4
Phase 3
0
Phase 4
0

Earliest trial started Jan 31, 2013 (NCT02779439)

Timeline

2010s

  1. Jan 1, 2013

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2021

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06075927Phase 1/Phase 2 (Phase 2)Nov 1, 2023Peking University
NCT05664126Phase 2Dec 31, 2022St. Jude Children's Hospital
NCT05075837Phase 1Dec 15, 2021University of Genoa
NCT04230356Phase 2Jan 27, 2021University of Cincinnati
NCT04013802Phase 1Sep 1, 2019Baylor University, Methodist Cancer Center, Houston, Texas
NCT03475212Phase 1/Phase 2 (Phase 2)Jun 20, 2018Children's Hospital Los Angeles, Children's National Medical Center
NCT03180216Phase 1Feb 15, 2017Georgetown University
NCT02779439Phase 1Jan 31, 2013University of Sydney
Showing 8 of 8 trials
Page 1 / 1

Organizations

Research & Development (10)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Baylor UniversityAcademic/Hospital1112019
Children's Hospital Los AngelesAcademic/Hospital1112018
Children's National Medical CenterAcademic/Hospital1012018
Georgetown UniversityAcademic/Hospital1112017
Methodist Cancer Center, Houston, TexasAcademic/Hospital1012019
Peking UniversityAcademic/Hospital1112023
St. Jude Children's HospitalAcademic/Hospital1112022
University of CincinnatiAcademic/Hospital1112021
University of GenoaAcademic/Hospital1112021
University of SydneyAcademic/Hospital1112013
10 organizations
Page 1 / 1